4//SEC Filing
HEMOSENSE INC 4
Accession 0001181431-07-067157
CIK 0001127393operating
Filed
Nov 6, 7:00 PM ET
Accepted
Nov 7, 2:00 PM ET
Size
17.2 KB
Accession
0001181431-07-067157
Insider Transaction Report
Form 4
STILL TIMOTHY I
Exec. VP, Sales and Marketing
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2007-11-06−1,668→ 0 totalExercise: $0.80Exp: 2015-02-17→ Common Stock (1,668 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-11-06−7,187→ 0 totalExercise: $8.60Exp: 2017-05-24→ Common Stock (7,187 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-11-06−15,000→ 0 totalExercise: $6.23Exp: 2016-02-06→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2007-11-06−22,813→ 0 totalExercise: $8.60Exp: 2017-05-24→ Common Stock (22,813 underlying) - Disposition to Issuer
Common Stock
2007-11-06−65,000→ 0 total - Disposition to Issuer
Common Stock
2007-11-06−10,832→ 0 total - Disposition to Issuer
Stock Option (right to buy)
2007-11-06−38,000→ 0 totalExercise: $3.95Exp: 2016-08-30→ Common Stock (38,000 underlying)
Footnotes (2)
- [F1]Disposed of pursuant to merger agreement between issuer and Inverness Medical Innovations, Inc. ("Inverness") in exchange for shares of Inverness common stock on the effective date of the merger, November 6, 2007. The number of shares of common stock issued by Inverness is equal to the number of shares of HemoSense common stock held multiplied by the exchange ratio of 0.274192, with the resulting aggregated share number rounded down to the next whole share and fractional shares paid in cash.
- [F2]This option was assumed by Inverness in the merger and replaced with an option to purchase shares of Inverness common stock. The number of shares of Inverness common stock subject to the assumed option is calculated by multiplying the number of shares of HemoSense common stock subject to the options held by 0.274192, rounded down on a per-option basis to the next whole share. The exercise price of the assumed option is equal to the exercise price of the HemoSense option divided by 0.274192, rounded up to the next cent.
Documents
Issuer
HEMOSENSE INC
CIK 0001127393
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001127393
Filing Metadata
- Form type
- 4
- Filed
- Nov 6, 7:00 PM ET
- Accepted
- Nov 7, 2:00 PM ET
- Size
- 17.2 KB